Sample size recalculation in Internal pilot study designs: A review

Biometrical Journal

Volumn 48, Issue 4, 2006, Pages 537-555

  Friede, Tim ^a   Kieser, Meinhard ^b,c  

^a NOVARTIS PHARMA AG   (Switzerland)

^b DR WILLMAR SCHWABE GMBH AND CO KG   (Germany)

^c UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Clinical trials; Internal pilot study; Nuisance parameter; Sample size recalculation

Indexed keywords

SAMPLING;

CLINICAL TRIAL; INTERNAL PILOT STUDY; MID COURSE; NUISANCE PARAMETER; PILOT STUDIES; PLANNING PHASIS; SAMPLE SIZE RECALCULATION; SAMPLE SIZES; SIZE CALCULATIONS; STUDY DESIGN;

UNCERTAINTY ANALYSIS;

EID: 33748550685     PISSN: 03233847     EISSN: 15214036     Source Type: Journal    
DOI: 10.1002/bimj.200510238     Document Type: Review

References (58)

1. Bauer, P. and Köhne, K. (1994). Evaluation of experiments with adaptive interim analyses. Biometrics 50, 1029-1041 (correction in Biometrics (1996); 52, 380).
2. 2-Kriteriums für kleine Versuchszahlen. Zeitschrift für Angewandte Mathematik und Mechanik 49, 634-636.
3. Berger, V. W. (2000). Pros and cons of permutation tests in clinical trials. Statistics in Medicine 19, 1319-1328.
4. Birkett, M. A. and Day, S. J. (1994). Internal pilot studies for estimating sample size. Statistics in Medicine 13, 2455-2463.
5. Bolland, K., Sooriyarachchi, M. R. and Whitehead, J. (1998). Sample size review in a head injury trial with ordered categorical responses. Statistics in Medicine 17, 2835-2847.
6. Browne, R. H. (1995). On the use of a pilot sample for sample size determination. Statistics in Medicine 14, 1933-1940.
7. Coffey, C. S. and Muller, K. E. (1999). Exact test size and power of a gaussian error linear model for an internal pilot study. Statistics in Medicine 18, 1199-1214.
8. Coffey, C. S. and Muller, K. E. (2001). Controlling test size while gaining the benefits of an internal pilot design. Biometrics 57, 625-631.
9. Coffey, C. S. and Muller, K. E. (2003). Properties of internal pilots with the univariate approach to repeated measures. Statistics in Medicine 22, 2469-2485.
10. Denne, J. S. and Jennison, C. (1999). Estimating the sample size for a t-test using an internal pilot. Statistics in Medicine 18, 1575-1585.
11. Dempster, A. P., Laird, N. M. and Rubin, D. B. (1977). Maximum likelihood from incomplete data via the EM algorithm (with discussion). Journal of the Royal Statistical Society Series B 39, 1-38.
12. Dick, N. P. and Bowden, D. C. (1973). Maximum likelihood estimation for mixtures of two normal distributions. Biometrics 29, 781-790.
13. Edgington, E. S. (1995). Randomization Tests. Marcel Dekker, New York.
14. Friede, T. and Kieser, M. (2001a). A comparison of methods for adaptive sample size adjustment. Statistics in Medicine 20, 3861-3873.
15. Friede, T. and Kieser, M. (2001b). Sample size adjustment in clinical trials for proving equivalence. Drug Information Journal 35, 1401-1408.
16. Friede, T. and Kieser, M. (2002). On the inappropriateness of an EM algorithm based procedure for blinded sample size re-estimation. Statistics in Medicine 21, 165-176.
17. Friede, T. and Kieser, M. (2003). Blinded sample size reassessment in non-inferiority and equivalence trials. Statistics in Medicine 22, 995-1007.
18. Friede, T. and Kieser, M. (2004). Sample size recalculation for binary data in internal pilot study designs. Pharmaceutical Statistics 3, 269-279.
19. Friede, T. and Kieser, M. (2005). Authors' reply. Statistics in Medicine 24, 154-156.
20. Galbraith, S. and Marschner, I. C. (2003). Interim monitoring of continuous long-term endpoints in clinical trials with longitudinal outcomes. Statistics in Medicine 22, 1787-1805.
21. Good, P. (1994). Permutation Tests. Springer, New York.
22. Gould, A. L. and Shih, W. J. (1992). Sample size re-estimation without unblinding for normally distributed out-comes with unknown variance. Communications in Statistics - Theory and Methods 21, 2833-2853.
23. Gould, A. L. (1992). Interim analyses for monitoring clinical trials that do not materially affect the type I error rate. Statistics in Medicine 11, 55-66.
24. Gould, A. L. and Shih, W. J. (2005). Letter to the Editor. Statistics in Medicine 24, 147-154.
25. Govindarajulu, Z. (2003). Robustness of sample size re-estimation procedure in clinical trials (arbitrary populations). Statistics in Medicine 22, 1819-1828. Correction in Statistics in Medicine 23, 2279.
26. Hauschke, D., Kieser, M., Diletti, E. and Burke, M. (1999). Sample size determination for proving equivalence based on the ratio of two means for normally distributed data. Statistics in Medicine 18, 93-105.
27. Herson, J. and Wittes, J. (1993). The use of interim analysis for sample size adjustment. Drug Information Journal 27, 753-760.
28. ICH: ICH Harmonized Tripartite Guideline E9 (1999). Statistical Principles for Clinical Trials. Statistics in Medicine 18, 1905-1942.
29. Kieser, M. and Friede, T. (2000a). Re-calculating the sample size in internal pilot study designs with control of the type I error rate. Statistics in Medicine 19, 901-911.
30. Kieser, M. and Friede, T. (2000b). Blinded sample size reestimation in multiarmed clinical trials. Drug Information Journal 34, 455-460.
31. Kieser, M. and Friede, T. (2003). Simple procedures for blinded sample size adjustment that do not affect the type I error rate. Statistics in Medicine 22, 3571-3581.
32. Kieser, M. and Hauschke, D. (1999). Approximate sample sizes for testing hypotheses about the ratio and difference of two means. Journal of Biopharmaceutical Statistics 9, 641-650.
33. Kieser, M. and Wassmer, G. (1996). On the use of the upper confidence limit for the variance from a pilot sample for sample size determination. Biometrical Journal 38, 941-949.
34. Lake, S., Kammann, E., Klar, N. and Betensky, R. (2002) Sample size re-estimation in cluster randomization trials. Statistics in Medicine 21, 1337-1350.
35. Linde, K. and Mulrow, C. D. (2000). St John's wort for depression (Cochrane Review). In: The Cochrane Library, Issue 3, 2000. Oxford: Update Software.
36. Marschner, I. C. and Becker, S. L. (2001). Interim monitoring of clinical trials based on long-term binary endpoints. Statistics in Medicine 20, 177-192.
37. McLachlan, G. J. and Krishnan, T. (1997). The EM Algorithm and Extensions. John Wiley and Sons, New York.
38. Mehrotra, D. V., Chan, I. S. F. and Berger, R. L. (2003). A cautionary note on exact unconditional inference for a difference between two independent binomial proportions. Biometrics 59, 441-450.
39. Miller, F. (2005). Variance estimation in clinical studies with interim sample size reestimation. Biometrics 61, 355-361.
40. Moshman, J. (1958). A method for selecting the size ofthe initial sample in Stein's two sample procedure. The Annals of Mathematical Statistics 29, 1271-1275.
41. Proschan, M. (2005). Two-stage sample size re-estimation based on a nuisance parameter: A review. Journal of Biopharmaceutical Statistics 15, 559-574.
42. Proschan, M. A. and Wittes, J. (2000). An improved double sampling procedure based on the variance. Biometrics 56, 1183-1187.
43. Sahai, H. and Khurshid, A. (1996). Formulae and tables for the determination of sample sizes and power in clinical trials for testing differences in proportions for the two-sample design: a review. Statistics in Medicine 15, 1-21.
44. Sandvik, L., Erikssen, J., Mowinckel, P. and Rodland, E. A. (1996). A method for determining the size of internal pilot studies. Statistics in Medicine 15, 1587-1590.
45. Seelbinder, B. M. (1953). On Stein's two-stage sampling scheme. The Annals of Mathematical Statistics 24, 640-649.
46. Shih, W. J. and Zhao, P.-L. (1997). Design for sample size re-estimation with interim data for double-blind clinical trials with binary outcomes. Statistics in Medicine 16, 1913-1923.
47. Singer, J. (1999). Letter to the editor: A method for determining the size of internal pilot studies. Statistics in Medicine 18, 1151-1153.
48. Stein, C. (1945). A two-sample test for a linear hypothesis whose power is independent of the variance. Annals of Mathematical Statistics 16, 243-258.
49. Steinijans, V. W., Sauter, R., Hauschke, D., Diletti, E., Schall, R., Luus, H. G., Elze, M., Blume, H., Hoffmann, C., Franke, G. and Siegmund, W. (1995). Reference tables for the intrasubject coefficient of variation in bioequivalence studies. International Journal of Clinical Pharmacology and Therapeutics 33, 427-430.
50. Storosum, J. G., Elferink, A. J. A., van Zwieten, B. J., van den Brink, W., Gersons, B. P. R., van Strik, R. and Broekmans, A. W. (2001). Short-term efficacy of tricyclic antidepresants revisited: a meta-analytic study. European Neuropsychopharmacology 11, 173-180.
51. Whitehead, J. (2001). Predicting the duration of sequential survival studies. Drug Information Journal 35, 1387-1400.
52. Whitehead, J., Whitehead, A., Todd, S., Bolland, K. and Sooriyarachchi, M. R. (2001). Mid-trial design reviews for sequential clinical trials. Statistics in Medicine 20, 165-176.
53. Wittes, J. and Brittain, E. (1990). The role of internal pilot studies in increasing the efficacy of clinical trials. Statistics in Medicine 9, 65-72.
54. Wittes, J., Schabenberger, O., Zucker, D., Brittain, E. and Proschan, M. (1999). Internal pilot studies I: type I error rate of the naive Mest. Statistics in Medicine 18, 3481-3491.
55. Wüst, K. and Kieser, M. (2003). Blinded sample size recalculation for normally distributed outcomes using longand short-term data. Biometrical Journal 45, 915-30.
56. Wüst, K. and Kieser, M. (2005). Including long- and short-term data in blinded sample size recalculation for binary endpoints. Computational Statistics Data Analysis 34, 835-855.
57. Zucker, D. M., Wittes, J. T., Schabenberger, O. and Brittain, E. (1999). Internal pilot studies II: comparison of various procedures. Statistics in Medicine 18, 3493-3509.
58. Zucker, D. M. and Denne, J. (2002). Sample size re-determination for repeated measures studies. Biometrics 48, 548-559.